Goran Engberg

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling.

Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling.

Journal: Translational psychiatry

Published: August 30, 2025

Effects of Heat Exposure on Kynurenine Pathway Metabolism-Comparison Between Exertional and Exogenous Heating of the Human Body.

Effects of Heat Exposure on Kynurenine Pathway Metabolism-Comparison Between Exertional and Exogenous Heating of the Human Body.

Journal: Acta physiologica (Oxford, England)

Published: August 28, 2025

Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.

Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.

Journal: The American journal of psychiatry

Published: April 01, 2025

Cardiovascular protein profiling in patients with first-episode psychosis.

Cardiovascular protein profiling in patients with first-episode psychosis.

Journal: Schizophrenia (Heidelberg, Germany)

Published: January 14, 2025

Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis.

Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis.

Journal: Brain, behavior, and immunity

Published: November 11, 2024

The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet-Examples of Recent Accomplishments and Future Perspectives.

The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet-Examples of Recent Accomplishments and Future Perspectives.

Journal: Pharmacological reviews

Published: August 15, 2024

Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.

Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.

Journal: Brain, behavior, and immunity

Published: July 02, 2024

Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis.

Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis.

Journal: Journal of psychiatric research

Published: September 18, 2023

Kynurenine Metabolites in CSF and Plasma in Healthy Males.

Kynurenine Metabolites in CSF and Plasma in Healthy Males.

Journal: International journal of tryptophan research : IJTR

Published: September 12, 2023

Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders.

Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders.

Journal: Acta neuropsychiatrica

Published: August 18, 2023

Preanalytic handling of clinical blood samples in assessing immunological proteins - Role of storage duration.

Preanalytic handling of clinical blood samples in assessing immunological proteins - Role of storage duration.

Journal: Brain, behavior, and immunity

Published: August 07, 2023

Disrupted-in-schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first-episode psychosis.

Disrupted-in-schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first-episode psychosis.

Journal: Psychiatry and clinical neurosciences

Published: May 10, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026